Cell Therapeutics, Inc.
CTIC is a buy as of Monday, March 30th, 2009 @ $0.35
I will hold and expect to sell around $0.80 possibly within a few days or by the end of the week. This stock has jumped from avg. volume of 9 million to 85 million. Alot of speculation about it’s new Pixantrone and how it is 81% more effective than the mainstream chemotherapy against the fight on cancer. The drug is now in phase III and is expecting fast track FDA approval into marketing and selling the drug by December. If this holds true, annual sales of one billion dollars by 2014 have been calculated.
[[T_F]]Data Leak Prevention – Data Security Solutions – Information Theft Protection, Detection and Prevention Software Productstracefusion_signature=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[[T_F]]
A young and savvy, yet experienced and accomplished investments mogul since ‘01; Michael has amassed a fortune as a private self investor. Recently starting his own successful blog and turning it in to a corporation — MIV Investments Inc., a company offering advice to thousands of people worldwide and attracting contracts from various reputable sources. His articles and publications have been linked to Forbes, CNN Money, Reuters, Bloomberg, and many other top worldwide mainstream media sources.
Michael Vlaicu
I just found this website.Just bookmarked it.Really like the “live Bloomberg TV”
Thanks alot Alex
Cell Genesys (CEGE) offers greater near term upside due to new finding of significant survival benefit and erroneous determination of deaths, including meaningful insider buying, strong cash position, and majority ownership of Ceregene who again advanced pivotal triials in gene therapy treatments. Once over .42 the stock could easily go to $1.00 short term. Company has value of at least $1.27 per share.
CTIC GO STRONG HOLD LONG!
Many people have lost their confidence in investing. However, even in a bad economy, there are good investment opportuntities. I happen to think stock in Mentor Capital (MNTR) is one of them.